Atlas Trials

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Clinical trial NCT01920477 · TERMINATED

Trial details

NCT number
NCT01920477
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Pemphigus Vulgaris
Start date
2013-08-13
Primary completion
2016-04-13
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.